ROYCE & ASSOCIATES LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 85 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2014$708,000
-34.4%
268,0000.0%0.00%
-33.3%
Q2 2014$1,080,000
-28.8%
268,000
-19.0%
0.00%
-25.0%
Q1 2014$1,516,000
-4.5%
331,000
-9.6%
0.00%
-20.0%
Q4 2013$1,588,000
-30.2%
366,000
-36.5%
0.01%
-28.6%
Q3 2013$2,275,000
+64.1%
576,000
-12.7%
0.01%
+75.0%
Q2 2013$1,386,000660,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2014
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders